Skip to main content
. 2023 Aug 31;137(16):1333–1346. doi: 10.1042/CS20230586

Table 1. Change in anthropometry after each cycle of weight loss in the T2D group.

Baseline, n=20 8 weeks, n=20 16 weeks, n=18 24 weeks, n=9 52 weeks, n=15 Control, n=20
Weight (kg) 71.8 ± 2.8 67.0 ± 2.7
P=0.0001
65.3 ± 2.9
P=0.0001
62.6 ± 4.2
P=0.0001
64.1 ± 2.8
P=0.0001
61.5 ± 2.5
P=0.496
BMI (kg/m2) 24.8 ± 0.4 23.2 ± 0.4
P=0.0001
22.4 ± 0.4
P=0.0001
21.3 ± 0.5
P=0.0001
22.4 ± 0.5
P=0.0001
21.5 ± 0.5
P=0.226
Change in BMI (%) - −6.6-± 0.5 −9.9-± 0.5 −14.1 ± 1.0 −9.9 ± 1.1
Fat free mass (kg) 49.0 ± 2.6 48.0 ± 2.6
P=0.004
47.5 ± 2.8
P=0.0001
46.6 ± 3.8
P=0.0001
47.1 ± 3.0
P=0.0001
46.4 ± 2.2
P=0.845
Total body fat (%) 32.1 ± 1.5 28.8 ± 1.6
P=0.0001
27.7 ± 1.5
P=0.0001
25.8 ± 2.3
P=0.0001
27.7 ± 1.8
P=0.0001
24.6 ± 1.5
P=0.214
 Female 36.3 ± 0.9 33.2 ± 1.0
P=0.0001
31.4 ± 1.0
P=0.0001
29.5 ± 1.7
P=0.0001
32.0 ± 0.9
P=0.0001
27.5±1.7
P=0.037
 Male 24.2 ± 1.2 20.6 ± 1.3
P=0.0001
20.3 ± 1.5
P=0.0001
19.2 ± 1.8
P=0.006
19.2 ± 1.7
P=0.983
Waist circumference (cm) 90.0 ± 2.1 83.4 ± 1.9
P=0.001
80.9 ± 2.1
P=0.001
77.2 ± 2.7
P=0.001
79.7 ± 2.0
P=0.001
75.6 ± 1.8
P=0.140
 Female 85.6 ± 2.0 79.7 ± 1.6
P=0.001
76.8 ± 1.7
P=0.001
73.6 ± 2.0 76.4 ± 1.4
P=0.001
71.1 ± 1.5
P=0.022
 Male 98.1 ± 3.0 90.3 ± 3.2
P=0.001
89.0 ± 3.5
P=0.001
86.8 ± 3.8
P=0.001
83.9 ± 2.1
P=0.534
VAT (cm2) 143.2 ± 17.7 104.9 ± 14.2
P=0.001
95.0 ± 15.1
P=0.001
78.7 ± 25.3
P=0.001
89.7 ± 14.4
P=0.001
51.2 ± 13.1
P=0.057
 Female 107 ± 12 79 ± 10
P=0.0001
71 ± 11
P=0.0001
56 ± 16
P=0.001
70 ± 9
P=0.001
26 ± 6
P=0.001
 Male 211 ± 34 153 ± 33
P=0.001
136 ± 33
P=0.0001
130 ± 35
P=0.011
98 ± 30
P=0.504
SAT (cm2) 201.3 ± 13.5 157.6 ± 11.8
P=0.001
144.8 ± 12.2
P=0.001
125.2 ± 17.4
P=0.001
147.9 ± 13.4
P=0.001
107.4 ± 11.9
P=0.031
 Female 216 ± 17 168 ± 13
P=0.002
160 ± 12
P=0.0001
133 ± 19
P=0.003
159 ± 14
P=0.0001
110 ± 16
P=0.034
 Male 174 ± 18 138 ± 22
P=0.001
120 ± 25
P=0.001
127 ± 29
P=0.005
102 ± 18
P=0.502

Mean ± SEM. Number stated is for the whole cohort of 13 female and 7 male participants. Male data are not shown for 24 weeks (third cycle) as n=3. The P-values for each time point vs. baseline are shown. For the control data, P refers to comparison with 52 week time point (P4).